Last updated on February 2019

BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.

Brief description of study

The study is designed to compare the effects of BI 425809 compared to placebo in patients with cognitive impairment due to Alzheimer's Disease.

Clinical Study Identifier: NCT02788513

Contact Investigators or Research Sites near you

Start Over

Boehringer Ingelheim Call Center

Neuropraxis M nchen S d, Unterhaching
Unterhaching, Germany
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.